J. Kevin Buchi
Kevin Buchi, , joined the Dicerna board of directors in August 2018 and was appointed Chairman of the Board in January 2019. Mr. Buchi is the former President and Chief Executive Officer of Cephalon, Inc. and previously served as corporate vice president of global branded products at Teva Pharmaceutical Industries Limited, after Teva acquired Cephalon in October 2011. Mr. Buchi also served as President and Chief Executive Officer of TetraLogic Pharmaceuticals.
Mr. Buchi joined Cephalon in 1991 and during his tenure, held various leadership positions, including Chief Financial Officer and Chief Operating Officer, before becoming Cephalon’s Chief Executive Officer in 2010. In addition, Mr. Buchi currently serves as a Director of Amneal Pharmaceuticals, Inc. and Benitec Biopharma Ltd. Mr. Buchi previously served on the boards of several pharmaceutical companies, including EPIRUS Biopharmaceuticals, Inc., Alexza Pharmaceuticals, Inc., and Forward Pharma A/S.